Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients
Abstract
:1. Introduction
2. The Attribution of Organic Diseases to Psychosomatic Factors Has a Long Tradition
3. Psychosomatic Disease Models for ME/CFS Are in Contradiction with Scientific Findings, Expert Opinions, and the Lived Experiences of Patients
4. The Vast Majority of Research Views ME/CFS as an Organic Disease
5. Chronic Diseases Include the Risk of Mental Comorbidities
6. How to Best Help Affected Patients
7. Conclusion: False Psychosomatic Attributions on the Etiology of ME/CFS Hinder Adequate Patient Care
Author Contributions
Funding
Conflicts of Interest
References
- Bretherick, A.D.; McGrath, S.J.; Devereux-Cooke, A.; Leary, S.; Northwood, E.; Redshaw, A.; Stacey, P.; Tripp, C.; Wilson, J.; Chowdhury, S.; et al. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study. NIHR Open Res. 2023, 3, 20. [Google Scholar] [CrossRef] [PubMed]
- Stussman, B.; Williams, A.; Snow, J.; Gavin, A.; Scott, R.; Nath, A.; Walitt, B. Characterization of post-exertional malaise in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Neurol. 2020, 11, 1025. [Google Scholar] [CrossRef] [PubMed]
- Cotler, J.; Holtzman, C.; Dudun, C.; Jason, L.A. A brief questionnaire to assess post-exertional malaise. Diagnostics 2018, 8, 66. [Google Scholar] [CrossRef] [PubMed]
- Kim, L.; Kedor, C.; Buttgereit, F.; Heidecke, H.; Schaumburg, D.; Scheibenbogen, C. Characterizing Sjögren-associated fatigue: A distinct phenotype from ME/CFS. J. Clin. Med. 2023, 12, 4994. [Google Scholar] [CrossRef] [PubMed]
- van Campen, C.L.M.C.; Verheugt, F.W.A.; Rowe, P.C.; Visser, F.C. Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). IBRO Neurosci. Rep. 2023, 15, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Carruthers, B.M.; Jain, A.K.; de Meirleir, K.L.; Peterson, D.L.; Klimas, N.G.; Lerner, A.M.; Bested, A.C.; Flor-Henry, P.; Joshi, P.; Powles, J.C.P.; et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 2003, 11, 7–115. [Google Scholar] [CrossRef]
- Jason, L.A.; Mirin, A.A. Updating the National Academy of Medicine ME/CFS prevalence and economic impact figures to account for population growth and inflation. Fatigue Biomed. Health Behav. 2021, 9, 9–13. [Google Scholar] [CrossRef]
- IQWIG. Myalgische Enzephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS)—Aktueller Kenntnissstand: [Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS)—Current Knowledge. 2023. Available online: https://www.iqwig.de/projekte/n21-01.html (accessed on 20 November 2023).
- Kedor, C.; Freitag, H.; Meyer-Arndt, L.; Wittke, K.; Hanitsch, L.G.; Zoller, T.; Steinbeis, F.; Haffke, M.; Rudolf, G.; Heidecker, B.; et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022, 13, 5104. [Google Scholar] [CrossRef]
- Bonilla, H.; Quach, T.C.; Tiwari, A.; Bonilla, A.E.; Miglis, M.; Yang, P.C.; Eggert, L.E.; Sharifi, H.; Horomanski, A.; Subramanian, A.; et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. Front. Neurol. 2023, 14, 1090747. [Google Scholar] [CrossRef]
- Mirin, A.A.; Dimmock, M.E.; Jason, L.A. Updated ME/CFS prevalence estimates reflecting post-COVID increases and associated economic costs and funding implications. Fatigue Biomed. Health Behav. 2022, 10, 83–93. [Google Scholar] [CrossRef]
- Roessler, M.; Tesch, F.; Batram, M.; Jacob, J.; Loser, F.; Weidinger, O.; Wende, D.; Vivirito, A.; Toepfner, N.; Ehm, F.; et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022, 19, e1004122. [Google Scholar] [CrossRef] [PubMed]
- Nelson, M.J.; Buckley, J.D.; Thomson, R.L.; Clark, D.; Kwiatek, R.; Davison, K. Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Transl. Med. 2019, 17, 80. [Google Scholar] [CrossRef]
- Lim, E.-J.; Kang, E.-B.; Jang, E.-S.; Son, C.-G. The prospects of the two-day cardiopulmonary exercise test (CPET) in ME/CFS patients: A meta-analysis. J. Clin. Med. 2020, 9, 4040. [Google Scholar] [CrossRef] [PubMed]
- Nacul, L.C.; Mudie, K.; Kingdon, C.C.; Clark, T.G.; Lacerda, E.M. Hand grip strength as a clinical biomarker for ME/CFS and disease severity. Front. Neurol. 2018, 9, 992. [Google Scholar] [CrossRef] [PubMed]
- Jäkel, B.; Kedor, C.; Grabowski, P.; Wittke, K.; Thiel, S.; Scherbakov, N.; Doehner, W.; Scheibenbogen, C.; Freitag, H. Hand grip strength and fatigability: Correlation with clinical parameters and diagnostic suitability in ME/CFS. J. Transl. Med. 2021, 19, 159. [Google Scholar] [CrossRef]
- Carruthers, B.M.; van de Sande, M.I.; de Meirleir, K.L.; Klimas, N.G.; Broderick, G.; Mitchell, T.; Staines, D.; Powles, A.C.; Speight, N.; Vallings, R.; et al. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011, 270, 327–338. [Google Scholar] [CrossRef]
- Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness; National Academies Press: Washington, DC, USA, 2015. [Google Scholar]
- Sotzny, F.; Blanco, J.; Capelli, E.; Castro-Marrero, J.; Steiner, S.; Murovska, M.; Scheibenbogen, C. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—Evidence for an autoimmune disease. Autoimmun. Rev. 2018, 17, 601–609. [Google Scholar] [CrossRef]
- Fluge, Ø.; Tronstad, K.J.; Mella, O. Pathomechanisms and possible interventions in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). J. Clin. Investig. 2021, 131, e150377. [Google Scholar] [CrossRef]
- Brenu, E.W.; van Driel, M.L.; Staines, D.R.; Ashton, K.J.; Ramos, S.B.; Keane, J.; Klimas, N.G.; Marshall-Gradisnik, S.M. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Transl. Med. 2011, 9, 81. [Google Scholar] [CrossRef]
- Eaton-Fitch, N.; Johnston, S.C.; Zalewski, P.; Staines, D.; Marshall-Gradisnik, S. Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: An Australian cross-sectional study. Qual. Life Res. 2020, 29, 1521–1531. [Google Scholar] [CrossRef]
- Nunes, J.M.; Kell, D.B.; Pretorius, E. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses. Blood Rev. 2023, 60, 101075. [Google Scholar] [CrossRef] [PubMed]
- Hoel, F.; Hoel, A.; Pettersen, I.K.; Rekeland, I.G.; Risa, K.; Alme, K.; Sørland, K.; Fosså, A.; Lien, K.; Herder, I.; et al. A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight 2021, 6, e149217. [Google Scholar] [CrossRef] [PubMed]
- Fluge, Ø.; Mella, O.; Bruland, O.; Risa, K.; Dyrstad, S.E.; Alme, K.; Rekeland, I.G.; Sapkota, D.; Røsland, G.V.; Fosså, A.; et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight 2016, 1, e89376. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Possible Causes. 2023. Available online: https://www.cdc.gov/me-cfs/about/possible-causes.html (accessed on 20 November 2023).
- van Campen, C.L.M.C.; Verheugt, F.W.A.; Rowe, P.C.; Visser, F.C. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clin. Neurophysiol. Pract. 2020, 5, 50–58. [Google Scholar] [CrossRef] [PubMed]
- van Campen, C.L.M.; Rowe, P.C.; Visser, F.C. Reductions in cerebral blood flow can be provoked by sitting in severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. Healthcare 2020, 8, 394. [Google Scholar] [CrossRef] [PubMed]
- van Campen, C.L.M.C.; Rowe, P.C.; Visser, F.C. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients. Clin. Neurophysiol. Pract. 2021, 6, 245–255. [Google Scholar] [CrossRef]
- Sandvik, M.K.; Sørland, K.; Leirgul, E.; Rekeland, I.G.; Stavland, C.S.; Mella, O.; Fluge, Ø. Endothelial dysfunction in ME/CFS patients. PLoS ONE 2023, 18, e0280942. [Google Scholar] [CrossRef]
- Scherbakov, N.; Szklarski, M.; Hartwig, J.; Sotzny, F.; Lorenz, S.; Meyer, A.; Grabowski, P.; Doehner, W.; Scheibenbogen, C. Peripheral endothelial dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. ESC Heart Fail. 2020, 7, 1064–1071. [Google Scholar] [CrossRef]
- Joseph, P.; Arevalo, C.; Oliveira, R.K.F.; Faria-Urbina, M.; Felsenstein, D.; Oaklander, A.L.; Systrom, D.M. Insights from invasive cardiopulmonary exercise testing of patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Chest 2021, 160, 642–651. [Google Scholar] [CrossRef]
- McCully, K.K.; Natelson, B.H. Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin. Sci. 1999, 97, 603–608. [Google Scholar] [CrossRef]
- Stevens, S.; Snell, C.; Stevens, J.; Keller, B.; VanNess, J.M. Cardiopulmonary exercise test methodology for assessing exertion intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Pediatr. 2018, 6, 242. [Google Scholar] [CrossRef] [PubMed]
- Mathew, S.J.; Mao, X.; Keegan, K.A.; Levine, S.M.; Smith, E.L.P.; Heier, L.A.; Otcheretko, V.; Coplan, J.D.; Shungu, D.C. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: An in vivo 3.0 T (1)H MRS imaging study. NMR Biomed. 2009, 22, 251–258. [Google Scholar] [CrossRef] [PubMed]
- Naviaux, R.K.; Naviaux, J.C.; Li, K.; Bright, A.T.; Alaynick, W.A.; Wang, L.; Baxter, A.; Nathan, N.; Anderson, W.; Gordon, E. Metabolic features of chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA 2016, 113, E5472–E5480. [Google Scholar] [CrossRef] [PubMed]
- Freitag, H.; Szklarski, M.; Lorenz, S.; Sotzny, F.; Bauer, S.; Philippe, A.; Kedor, C.; Grabowski, P.; Lange, T.; Riemekasten, G.; et al. Autoantibodies to vasoregulative G-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Clin. Med. 2021, 10, 3675. [Google Scholar] [CrossRef] [PubMed]
- Loebel, M.; Grabowski, P.; Heidecke, H.; Bauer, S.; Hanitsch, L.G.; Wittke, K.; Meisel, C.; Reinke, P.; Volk, H.-D.; Fluge, Ø.; et al. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav. Immun. 2016, 52, 32–39. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, S.; Kuratsune, H.; Hidaka, Y.; Hakariya, Y.; Tatsumi, K.-I.; Takano, T.; Kanakura, Y.; Amino, N. Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int. J. Mol. Med. 2003, 12, 225–230. [Google Scholar] [CrossRef]
- van Campen, C.M.C.; Rowe, P.C.; Visser, F.C. Worsening symptoms is associated with larger cerebral blood flow abnormalities during tilt-testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Medicina 2023, 59, 2153. [Google Scholar] [CrossRef]
- Jason, L.A.; Cotler, J.; Islam, M.F.; Sunnquist, M.; Katz, B.Z. Risks for developing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in college students following infectious mononucleosis: A prospective cohort study. Clin. Infect. Dis. 2021, 73, e3740–e3746. [Google Scholar] [CrossRef]
- Choutka, J.; Jansari, V.; Hornig, M.; Iwasaki, A. Unexplained post-acute infection syndromes. Nat. Med. 2022, 28, 911–923. [Google Scholar] [CrossRef]
- McManimen, S.; McClellan, D.; Stoothoff, J.; Gleason, K.; Jason, L.A. Dismissing chronic illness: A qualitative analysis of negative health care experiences. Health Care Women Int. 2019, 40, 241–258. [Google Scholar] [CrossRef]
- Habermann-Horstmeier, L.; Horstmeier, L.M. Die ärztliche Wahrnehmung von ME/CFS-Erkrankten (myalgische Enzephalomyelitis/chronisches Fatigue-Syndrom) als „schwierige Patienten“: [Physician’s perception of ME/CFS sufferers as “difficult patients” A mainly qualitative public health study from a patient perspective]. Präv Gesundheitsf. 2023, 1–14. [Google Scholar] [CrossRef]
- Pheby, D.F.H.; Araja, D.; Berkis, U.; Brenna, E.; Cullinan, J.; de Korwin, J.-D.; Gitto, L.; Hughes, D.A.; Hunter, R.M.; Trepel, D.; et al. A literature review of GP knowledge and understanding of ME/CFS: A report from the socioeconomic working group of the European Network on ME/CFS (EUROMENE). Medicina 2021, 57, 7. [Google Scholar] [CrossRef]
- Jason, L.A.; Katz, B.Z.; Sunnquist, M.; Torres, C.; Cotler, J.; Bhatia, S. The prevalence of pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in a community-based sample. Child. Youth Care Forum. 2020, 49, 563–579. [Google Scholar] [CrossRef] [PubMed]
- Kellner, R. Psychosomatic syndromes, somatization and somatoform disorders. Psychother. Psychosom. 1994, 61, 4–24. [Google Scholar] [CrossRef] [PubMed]
- Yoshihara, K.; Kubo, C. Psychosomatic disorder and functional somatic syndrome. Nihon Rinsho 2009, 67, 1652–1658. [Google Scholar] [PubMed]
- Henningsen, P.; Zipfel, S.; Sattel, H.; Creed, F. Management of functional somatic syndromes and bodily distress. Psychother. Psychosom. 2018, 87, 12–31. [Google Scholar] [CrossRef]
- Ackerknecht, E.H. The history of psychosomatic medicine. Psychol. Med. 1982, 12, 17–24. [Google Scholar] [CrossRef]
- Alexander, F. Psychsomoatic Medicine: Its Principles and Applications; W. W. Norton & Co.: New York, NY, USA, 1950. [Google Scholar]
- Häuser, W.; Burgmer, M.; Köllner, V.; Schaefert, R.; Eich, W.; Hausteiner-Wiehle, C.; Henningsen, P. Das Fibromyalgiesyndrom als psychosomatische Erkrankung—Empfehlungen Aktueller Evidenzbasierter Leitlinien zu Diagnostik und Therapie: [Fibromyalgia as a psychsomatic illness—Recoomendations of current evidence-based criteria for diagnosis and therapy]. Z. Psychosom. Med. Psychother. 2013, 59, 132–152. [Google Scholar]
- Eriksson, E.M.; Andrén, K.I.; Kurlberg, G.K.; Eriksson, H.T. Aspects of the non-pharmacological treatment of irritable bowel syndrome. World J. Gastroenterol. 2015, 21, 11439–11449. [Google Scholar] [CrossRef]
- Lütje, W.; Brandenburg, U. Psychosomatische Aspekte der Endometriose: [Psychosomatic aspects of endometriosis]. Zentralbl Gynakol. 2003, 125, 281–285. [Google Scholar] [CrossRef]
- Marks, D.F. The rise and fall of the psychosomatic approach to medically unexplained symptoms, Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. Arch. Epidemiol. Public Health Res. 2022, 1, 97–144. [Google Scholar] [CrossRef]
- McEvedy, C.P.; Beard, A.W. Royal Free epidemic of 1955: A reconsideration. Br. Med. J. 1970, 1, 7–11. [Google Scholar] [CrossRef] [PubMed]
- Waters, F.G.; McDonald, G.J.; Banks, S.; Waters, R.A. Myalgic Encephalomyelitis (ME) outbreaks can be modelled as an infectious disease: A mathematical reconsideration of the Royal Free Epidemic of 1955. Fatigue Biomed. Health Behav. 2020, 8, 70–83. [Google Scholar] [CrossRef]
- White, P.D.; Goldsmith, K.A.; Johnson, A.L.; Potts, L.; Walwyn, R.; DeCesare, J.C.; Baber, H.L.; Burgess, M.; Clark, L.V.; Cox, D.L.; et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): A randomised trial. Lancet 2011, 377, 823–836. [Google Scholar] [CrossRef] [PubMed]
- Ludwig, B.; Olbert, E.; Trimmel, K.; Seidel, S.; Rommer, P.S.; Müller, C.; Struhal, W.; Berger, T. Myalgische Enzephalomyelitis/chronisches Fatigue-Syndrom: Eine Übersicht zur aktuellen Evidenz. [Myalgic encephalomyelitis/chronic fatigue syndrome: An overview of current evidence]. Nervenarzt. 2023, 94, 725–733. [Google Scholar] [CrossRef]
- Hng, K.N.; Geraghty, K.; Pheby, D.F.H. An audit of UK hospital doctors’ knowledge and experience of Myalgic Encephalomyelitis. Medicina 2021, 57, 885. [Google Scholar] [CrossRef]
- Tschopp, R.; König, R.S.; Rejmer, P.; Paris, D.H. Health system support among patients with ME/CFS in Switzerland. J. Taibah Univ. Med. Sci. 2023, 18, 876–885. [Google Scholar] [CrossRef]
- U.S. ME/CFS Clinician Coalition. What is ME/CFS? 2021. Available online: https://mecfscliniciancoalition.org/about-mecfs/ (accessed on 20 November 2023).
- Jackson, S. Online halth cmmunities in controversy over ME/CFS and Long Covid. Eur. J. Health Commun. 2023, 4, 49–72. [Google Scholar] [CrossRef]
- Wessely, S.; David, A.; Butler, S.; Chalder, T. Management of chronic (post-viral) fatigue syndrome. J. R. Coll. Gen. Pract. 1989, 39, 26–29. [Google Scholar]
- Vercoulen, J.; Swanink, C.; Galama, J.; Fennis, J.; Jongen, P.; Hommes, O.; van der Meer, J.; Bleijenberg, G. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis. J. Psychosom. Res. 1998, 45, 507–517. [Google Scholar] [CrossRef]
- Song, S.; Jason, L.A. A population-based study of Chronic Fatigue Syndrome (CFS) experienced in differing patient groups: An effort to replicate Vercoulen et al.’s model of CFS. J. Ment. Health 2005, 14, 277–289. [Google Scholar] [CrossRef]
- Geraghty, K.; Jason, L.A.; Sunnquist, M.; Tuller, D.; Blease, C.; Adeniji, C. The ‘cognitive behavioural model’ of Chronic Fatigue Syndrome: Critique of a flawed model. Health Psychol. Open 2019, 6, 2055102919838907. [Google Scholar] [CrossRef] [PubMed]
- Sunnquist, M.; Jason, L.A. A reexamination of the cognitive behavioral model of Chronic Fatigue Syndrome. J. Clin. Psychol. 2018, 74, 1234–1245. [Google Scholar] [CrossRef] [PubMed]
- Sanal-Hayes, N.E.M.; Mclaughlin, M.; Hayes, L.D.; Mair, J.L.; Ormerod, J.; Carless, D.; Hilliard, N.; Meach, R.; Ingram, J.; Sculthorpe, N.F. A scoping review of ‘Pacing’ for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Lessons learned for the long COVID pandemic. J. Transl. Med. 2023, 21, 720. [Google Scholar] [CrossRef] [PubMed]
- Bateman, L.; Bested, A.C.; Bonilla, H.F.; Chheda, B.V.; Chu, L.; Curtin, J.M.; Dempsey, T.T.; Dimmock, M.E.; Dowell, T.G.; Felsenstein, D.; et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of diagnosis and management. Mayo Clin. Proc. 2021, 96, 2861–2878. [Google Scholar] [CrossRef] [PubMed]
- Goudsmit, E.M.; Nijs, J.; Jason, L.A.; Wallman, K.E. Pacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome: A consensus document. Disabil. Rehabil. 2012, 34, 1140–1147. [Google Scholar] [CrossRef] [PubMed]
- Bested, A.C.; Marshall, L.M. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An evidence-based approach to diagnosis and management by clinicians. Rev. Environ. Health 2015, 30, 223–249. [Google Scholar] [CrossRef]
- Geraghty, K.; Hann, M.; Kurtev, S. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients’ reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys. J. Health Psychol. 2019, 24, 1318–1333. [Google Scholar] [CrossRef]
- National Institute for Health Care Excellence. Myalgic Encephalomyelitis (or Encephalopathy)/Chronic Fatigue Syndrome: Diagnosis and Management: NICE Guideline [NG206]. 2021. Available online: https://www.nice.org.uk/guidance/ng206 (accessed on 20 November 2023).
- Chu, L.; Valencia, I.J.; Garvert, D.W.; Montoya, J.G. Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey. PLoS ONE 2018, 13, e0197811. [Google Scholar] [CrossRef]
- Franklin, J.D.; Graham, M. Repeated maximal exercise tests of peak oxygen consumption in people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A systematic review and meta-analysis. Fatigue Biomed. Health Behav. 2022, 10, 119–135. [Google Scholar] [CrossRef]
- Moore, G.E.; Keller, B.A.; Stevens, J.; Mao, X.; Stevens, S.R.; Chia, J.K.; Levine, S.M.; Franconi, C.J.; Hanson, M.R. Recovery from exercise in persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Medicina 2023, 59, 571. [Google Scholar] [CrossRef]
- Light, A.R.; Bateman, L.; Jo, D.; Hughen, R.W.; Vanhaitsma, T.A.; White, A.T.; Light, K.C. Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. J. Intern. Med. 2012, 271, 64–81. [Google Scholar] [CrossRef] [PubMed]
- Nepotchatykh, E.; Elremaly, W.; Caraus, I.; Godbout, C.; Leveau, C.; Chalder, L.; Beaudin, C.; Kanamaru, E.; Kosovskaia, R.; Lauzon, S.; et al. Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology. Sci. Rep. 2020, 10, 19620. [Google Scholar] [CrossRef] [PubMed]
- Bond, J.; Nielsen, T.; Hodges, L. Effects of post-exertional malaise on markers of arterial stiffness in individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Int. J. Environ. Res. Public Health 2021, 18, 2366. [Google Scholar] [CrossRef] [PubMed]
- Ghali, A.; Lacout, C.; Ghali, M.; Gury, A.; Beucher, A.-B.; Lozac’h, P.; Lavigne, C.; Urbanski, G. Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome. Sci. Rep. 2019, 9, 18817. [Google Scholar] [CrossRef]
- van Campen, C.L.M.C.; Rowe, P.C.; Visser, F.C. Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome). J. Transl. Med. 2021, 19, 193. [Google Scholar] [CrossRef]
- Froehlich, L.; Hattesohl, D.B.R.; Cotler, J.; Jason, L.A.; Scheibenbogen, C.; Behrends, U. Causal attributions and perceived stigma for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Health Psychol. 2022, 27, 2291–2304. [Google Scholar] [CrossRef]
- Ware, N.C. Suffering and the social construction of Illness: The delegitimation of illness experience in Chronic Fatigue Syndrome. Med. Anthropol. Q. 1992, 6, 347–361. [Google Scholar] [CrossRef]
- Green, J.; Romei, J.; Natelson, B.H. Stigma and Chronic Fatigue Syndrome. J. Chronic Fatigue Syndr. 1999, 5, 63–75. [Google Scholar] [CrossRef]
- Baken, D.M.; Harvey, S.T.; Bimler, D.L.; Ross, K.J. Stigma in Myalgic Encephalomyelitis and its association with functioning. Fatigue Biomed. Health Behav. 2018, 6, 30–40. [Google Scholar] [CrossRef]
- McManimen, S.L.; McClellan, D.; Stoothoff, J.; Jason, L.A. Effects of unsupportive social interactions, stigma, and symptoms on patients with myalgic encephalomyelitis and chronic fatigue syndrome. J. Community Psychol. 2018, 46, 959–971. [Google Scholar] [CrossRef] [PubMed]
- Dickson, A.; Knussen, C.; Flowers, P. Stigma and the delegitimation experience: An interpretative phenomenological analysis of people living with chronic fatigue syndrome. Psychol. Health 2007, 22, 851–867. [Google Scholar] [CrossRef]
- Habermann-Horstmeier, L.; Horstmeier, L.M. Auswirkungen der Qualität der Arzt-Patient-Beziehung auf die Gesundheit von erwachsenen ME/CFS-Erkrankten: Eine qualitative Public-Health-Studie aus Patientensicht: [Consequences of the quality of the doctor-patient-relationship on the health of adult patients with ME/CFS: A qualitative public health study from the patients’ perspective]. [Implications of the quality of the doctor-patient relationship on health in adult ME/CFS patients. A qualitative public health study from a patien perspective]. MMW Fortschr. Med. 2023, 165, 16–27. [Google Scholar] [CrossRef]
- Vink, M.; Vink-Niese, A. The updated NICE guidance exposed the serious flaws in CBT and graded exercise therapy trials for ME/CFS. Healthcare 2022, 10, 898. [Google Scholar] [CrossRef] [PubMed]
- Deter, H.-C.; Kruse, J.; Zipfel, S. History, aims and present structure of psychosomatic medicine in Germany. Biopsychosoc. Med. 2018, 12, 1. [Google Scholar] [CrossRef] [PubMed]
- Peterson, T.M.; Peterson, T.W.; Emerson, S.; Regalbuto, E.; Evans, M.; Jason, L.A. Coverage of CFS within U.S. medical textbooks. Univers. J. Public Health 2013, 1, 177–179. [Google Scholar] [CrossRef]
- Saunders, C.; Sperling, S.; Bendstrup, E. A new paradigm is needed to explain long COVID. Lancet Respir. Med. 2023, 11, e12–e13. [Google Scholar] [CrossRef]
- Cornish, F.; Stelson, E.A. Concerns regarding a suggested long COVID paradigm. Lancet Respir. Med. 2023, 11, e35. [Google Scholar] [CrossRef]
- Muller, A.E.; Tveito, K.; Bakken, I.J.; Flottorp, S.A.; Mjaaland, S.; Larun, L. Potential causal factors of CFS/ME: A concise and systematic scoping review of factors researched. J. Transl. Med. 2020, 18, 484. [Google Scholar] [CrossRef]
- Siegel, Z.A.; Brown, A.; Devendorf, A.; Collier, J.; Jason, L.A. A content analysis of chronic fatigue syndrome and myalgic encephalomyelitis in the news from 1987 to 2013. Chronic Illn. 2018, 14, 3–12. [Google Scholar] [CrossRef]
- Light, N.; Fernbach, P.M.; Rabb, N.; Geana, M.V.; Sloman, S.A. Knowledge overconfidence is associated with anti-consensus views on controversial scientific issues. Sci. Adv. 2022, 8, eabo0038. [Google Scholar] [CrossRef]
- Froehlich, L.; Niedrich, J.; Hattesohl, D.B.R.; Behrends, U.; Kedor, C.; Haas, J.-P.; Stingl, M.; Scheibenbogen, C. Evaluation of a webinar to increase health professionals’ knowledge about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Healthcare 2023, 11, 2186. [Google Scholar] [CrossRef]
- Griffith, J.P.; Zarrouf, F.A. A systematic review of chronic fatigue syndrome: Don’t assume it’s depression. Prim. Care Companion J. Clin. Psychiatry 2008, 10, 120–128. [Google Scholar] [CrossRef]
- Hawk, C.; Jason, L.A.; Torres-Harding, S. Differential diagnosis of chronic fatigue syndrome and major depressive disorder. Int. J. Behav. Med. 2006, 13, 244–251. [Google Scholar] [CrossRef]
- Waclawovsky, A.J.; de Brito, E.; Smith, L.; Vancampfort, D.; Da Silva, A.M.V.; Schuch, F.B. Endothelial dysfunction in people with depressive disorders: A systematic review and meta-analysis. J. Psychiatr. Res. 2021, 141, 152–159. [Google Scholar] [CrossRef]
- Shinba, T.; Kuratsune, D.; Shinba, S.; Shinba, Y.; Sun, G.; Matsui, T.; Kuratsune, H. Major Depressive Disorder and Chronic Fatigue Syndrome Show Characteristic Heart Rate Variability Profiles Reflecting Autonomic Dysregulations: Differentiation by Linear Discriminant Analysis. Sensors 2023, 23, 5330. [Google Scholar] [CrossRef]
- Froehlich, L.; Hattesohl, D.B.R.; Jason, L.A.; Scheibenbogen, C.; Behrends, U.; Thoma, M. Medical care situation of people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany. Medicina 2021, 57, 646. [Google Scholar] [CrossRef]
- Rücker, M. Diagnose Chronisches Fatigue-Syndrom: Auf der Suche nach Atlantis: [Diagnosis Chronic Fatigue Syndrome: Searching for Atlantis]. Taz, 18 June 2023. [Google Scholar]
- Weber, N. Long COVID und ME/CFS: Wenn Selbst Zum Zähneputzen die Kraft Fehlt: [Long COVID and ME/CFS: When You Don’t Have the Strength to Even Brush Your Teeth]; Der Spiegel: Hamburg, Germany, 2022; Volume 39. [Google Scholar]
- #ME-Action. The Effects of Graded Exercise Therapy and Positive Thinking on a Young Girl with ME. 2019. Available online: https://www.meaction.net/2019/01/23/the-effects-of-graded-exercise-therapy-and-positive-thinking-on-a-young-girl-with-me/ (accessed on 20 November 2023).
- Grande, T.; Grande, B.; Gerner, P.; Hammer, S.; Stingl, M.; Vink, M.; Hughes, B.M. The role of psychotherapy in the care of patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Medicina 2023, 59, 719. [Google Scholar] [CrossRef]
- European Parliament. COVID-19 Pandemic: Lessons Learned and Recommendations for the Future: European Parliament Resolution of 12 July 2023. 2023. Available online: https://uploads-ssl.webflow.com/61b63231cb96a382c9cebd5c/64b5563977b483cb370fdfd1_Ergebnisse%20Covi-Bericht_Auswahl.pdf (accessed on 20 November 2023).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Thoma, M.; Froehlich, L.; Hattesohl, D.B.R.; Quante, S.; Jason, L.A.; Scheibenbogen, C. Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients. Medicina 2024, 60, 83. https://doi.org/10.3390/medicina60010083
Thoma M, Froehlich L, Hattesohl DBR, Quante S, Jason LA, Scheibenbogen C. Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients. Medicina. 2024; 60(1):83. https://doi.org/10.3390/medicina60010083
Chicago/Turabian StyleThoma, Manuel, Laura Froehlich, Daniel B. R. Hattesohl, Sonja Quante, Leonard A. Jason, and Carmen Scheibenbogen. 2024. "Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients" Medicina 60, no. 1: 83. https://doi.org/10.3390/medicina60010083